首页
订购/客服:400-666-5481

SB 242235

    
≥99%

SB 242235

源叶(MedMol)
S84188 一键复制产品信息
193746-75-7
C19H20FN5O
353.3934
Kinome_3169; HMS3244I18; 4-(4-(4-fluorophenyl)-1-(piperidin-4-yl)-1H-imidazol-5-yl)-2-methoxypyrimidine; HMS3244I17; HMS3244J17;
货号 规格 价格 上海 北京 珠海 重庆 武汉 购买数量
S84188-1mg
≥99%

¥295.00

货期:3-5天 - - - -
S84188-2mg
≥99%

¥425.00

货期:3-5天 - - - -
S84188-5mg
≥99%

¥690.00

货期:3-5天 - - - -
S84188-10mg
≥99%

¥1180.00

货期:3-5天 - - - -
S84188-25mg
≥99%

¥2500.00

货期:3-5天 - - - -
S84188-50mg
≥99%

¥3700.00

货期:3-5天 - - - -
S84188-100mg
≥99%

¥5400.00

货期:3-5天 - - - -
产品介绍 参考文献 质检证书(COA) 摩尔浓度计算器 相关产品
产品描述: SB-242235 is a potent and selective p38 MAP kinase inhibitor, with an IC50 of 1.0 μM in primary human chondrocytes
靶点: IC50: 1.0 μM (p38 MAPK, primary human chondrocytes);p38MAPK; Autophagy
体外研究: SB 242235 (0-10 μM) dose-dependently inhibits the activation of MAPKAP K2 with an IC50 of 1.0 μM in human chondrocytes stimulated with IL-1β. SB 242235 inhibits intracellular p38 activity, MAPKAP K2 was then isolated from these cells and assayed using HSP27 as a substrate. Western Blot Analysis Cell Line: Human chondrocytes Concentration: 0 μM,0.01 μM,0.1 μM,1 μM,10 μM Incubation Time: 15 minutes Result: Dose-dependently inhibited the activation of MAPKAP K2 with an IC50 of 1.0 μM.
体内研究: SB242235 (100 mg/kg; p.o.) abolishes MAP-KAPK-2 activity and HSP27 phosphorylation. SB242235 inhibits expression of the pro-inflammatory cytokines interleukin (IL)-6 and KC (murine IL-8) and COX-2. SB-242235 is demonstrated non-linear elimination kinetics that manifested as a decrease in clearance with increasing dose and apparent oral bioavailability > 100% at high oral doses in rat and monkey. Animal Model: Female SKH-1 hairless mice (4–6 weeks) Dosage: 100 mg/kg Administration: Oral administered, 30 minutes prior to ultraviolet B (UVB) irradiation Result: Abolished MAP-KAPK-2 activity and heat shock protein 27 (HSP27) phosphorylation.
参考文献: 1. Badger, A.M., et al., Differential effects of SB 242235, a selective p38 mitogen-activated protein kinase inhibitor, on IL-1 treated bovine and human cartilage/chondrocyte cultures. Osteoarthritis Cartilage, 2000. 8(6): p. 434-43. 2. Kim AL , et al. Role of p38 MAPK in UVB-induced inflammatory responses in the skin of SKH-1 hairless mice. J Invest Dermatol. 2005 Jun;124(6):1318-25. 3. Ward, K.W., et al., SB-242235, a selective inhibitor of p38 mitogen-activated protein kinase. I: preclinical pharmacokinetics. Xenobiotica, 2002. 32(3): p. 221-33.
溶解性: soluble  in  DMSO
保存条件: -20℃
配置溶液浓度参考:
1mg 5mg 10mg
1 mM 2.83 ml 14.149 ml 28.297 ml
5 mM 0.566 ml 2.83 ml 5.659 ml
10 mM 0.283 ml 1.415 ml 2.83 ml
50 mM 0.057 ml 0.283 ml 0.566 ml
注意: 部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。

参考文献

质检证书(COA)

如何获取质检证书(COA)?
请输入货号和一个与之匹配的批号。
例如:
批号:JS298415 货号:S20001-25g
在货品标签上如何找到货号和批号?

摩尔浓度计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)

=
×
×